FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thoralf Lange

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Phenomena

Recurrence

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Thoralf Lange; Jacqueline Maier; Claudia Nehring; Dietger Niederwieser; Udo Siebolts; Michael Cross; Anja Edelmann; Nadja Jäkel; Rainer Krahl; Claudia Wickenhauser
JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse.
Jamshid Sorouri Khorashad; Ira L Kraft; Thoralf Lange; David Marin; Clinton C Mason; Thomas O'Hare; Anthony D Pomicter; Alistair G Reid; Simona Soverini; Philippe Szankasi; Matthew S Zabriskie; Lauren T Adrian; Mary Alikian; David J Anderson; Brian J Druker; Christopher A Eide; Anna Eiring; Johanna C Estrada; Letizia Foroni; Zhimin Gu; Todd W Kelley; Michael W N Deininger
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.
Enrica Bach; Thomas Büchner; Haifa-Kathrin Al-Ali; Gottfried Dölken; Torsten Haferlach; Rainer Krahl; Thoralf Lange; Dietger Niederwieser; Frank Schüler; Michael Cross
Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thoralf Lange (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thoralf Lange; Jacqueline Maier; Claudia Nehring; Dietger Niederwieser; Udo Siebolts; Michael Cross; Anja Edelmann; Nadja Jäkel; Rainer Krahl; Claudia Wickenhauser
JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse.
Haematologica 2013;98(5):722-8.
2013: Jamshid Sorouri Khorashad; Ira L Kraft; Thoralf Lange; David Marin; Clinton C Mason; Thomas O'Hare; Anthony D Pomicter; Alistair G Reid; Simona Soverini; Philippe Szankasi; Matthew S Zabriskie; Lauren T Adrian; Mary Alikian; David J Anderson; Brian J Druker; Christopher A Eide; Anna Eiring; Johanna C Estrada; Letizia Foroni; Zhimin Gu; Todd W Kelley; Michael W N Deininger
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.
Blood 2013;121(3):489-98.
2012: Enrica Bach; Thomas Büchner; Haifa-Kathrin Al-Ali; Gottfried Dölken; Torsten Haferlach; Rainer Krahl; Thoralf Lange; Dietger Niederwieser; Frank Schüler; Michael Cross
Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemia.
Leukemia & lymphoma 2012;53(8):1561-8.
2012: Sabine Tschiedel; Vladan Vucinic; Song-Yau Wang; Haifa-Kathrin Al-Ali; Enrica Bach; Annette Jilo; Thoralf Lange; Dietger Niederwieser; Michael Cross
Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia.
Leukemia & lymphoma 2012;53(8):1569-76.
2012: Heike Pfeifer; M Schmalzing; A Schmidt; Hubert Serve; Matthias Stelljes; Barbara Wassmann; Lydia Wunderle; S Wystub; Anja Binckebanck; Patrick Brück; Ulrich Dührsen; Aristoteles Giagounidis; Dieter Hoelzer; Thoralf Lange; J Maier; Oliver G Ottmann
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
Leukemia 2012;26(7):1475-81.
2011: Haifa-Kathrin Al-Ali; N Basara; M Bourgeois; E Edel; Rainer Krahl; Thoralf Lange; Sabine Leiblein; W Poenisch; Dietger Niederwieser
The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2011;46(10):1296-302.
2011: Ron Ram; Brenda M Sandmaier; Rainer Storb; Barry Storer; Ann Woolfrey; Thoralf Lange; Amelia A Langston; Ginna G Laport; David G Maloney; Michael B Maris; Thomas R Chauncey; Mary E D Flowers; George E Georges
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Haematologica 2011;96(8):1113-20.
2011: Thoralf Lange; M Hubmann; R Burkhardt; G-N Franke; Michael Cross; M Scholz; Sabine Leiblein; Haifa-Kathrin Al-Ali; J Edelmann; J Thiery; Dietger Niederwieser
Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning.
Leukemia 2011;25(3):498-505.
2010: Daniel W Sherbenou; Oliver Hantschel; Ines Kaupe; Stephanie Willis; Thomas Bumm; Lalita P Turaga; Thoralf Lange; Kim-Hien Dao; Richard D Press; Brian J Druker; Giulio Superti-Furga; Michael W N Deininger
BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib.
Blood 2010;116(17):3278-85.
2010: Claudia Michael; Uta Bierbach; Katrin Frenzel; Thoralf Lange; Nadezda Basara; Dietger Niederwieser; Christine Mauz-Körholz; Rainer Preiss
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients.
Antimicrobial agents and chemotherapy 2010;54(8):3225-32.
2010: Boglarka Gyurkocza; Rainer Storb; Barry E Storer; Thomas R Chauncey; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Christopher N Bredeson; Richard T Maziarz; Benedetto Bruno; Finn B Petersen; Michael B Maris; Edward Agura; Andrew Yeager; Wolfgang A Bethge; Firoozeh Sahebi; Frederick R Appelbaum; David G Maloney; Brenda M Sandmaier
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2859-67.
2010: Udo Siebolts; Thoralf Lange; Dietger Niederwieser; Claudia Wickenhauser
Allele-specific wild-type blocker quantitative PCR for highly sensitive detection of rare JAK2 p.V617F point mutation in primary myelofibrosis as an appropriate tool for the monitoring of molecular remission following therapy.
Journal of clinical pathology 2010;63(4):370-2.
2010: Shannon McWeeney; Lucy C Pemberton; Marc Loriaux; Kristina Vartanian; Stephanie G Willis; Gregory Yochum; Beth Wilmot; Yaron Turpaz; Raji Pillai; Brian J Druker; Jennifer L Snead; Mary MacPartlin; Stephen G O'Brien; Junia V Melo; Thoralf Lange; Christina A Harrington; Michael W N Deininger
A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib.
Blood 2010;115(2):315-25.
2009: Jennifer L Snead; Thomas O'Hare; Lauren T Adrian; Christopher A Eide; Thoralf Lange; Brian J Druker; Michael W N Deininger
Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosis.
Blood 2009;114(16):3459-63.
2009: Thomas Ernst; Franz X Gruber; Oliver Pelz-Ackermann; Jacqueline Maier; Markus Pfirrmann; Martin C Müller; Ingvild Mikkola; Kimmo Porkka; Dietger Niederwieser; Andreas Hochhaus; Thoralf Lange
A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib.
Haematologica 2009;94(9):1227-35.
2009: Haifa-Kathrin Al-Ali; Michael Cross; Thoralf Lange; Matthias Freund; Gottfried Dölken; Dietger Niederwieser
Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
Current opinion in oncology 2009;21 Suppl 1():S17-22.
2009: Marcello Rotta; Barry E Storer; Firoozeh Sahebi; Judith A Shizuru; Benedetto Bruno; Thoralf Lange; Edward D Agura; Peter A McSweeney; Michael Allen Pulsipher; Parameswaran Hari; Richard T Maziarz; Thomas R Chauncey; Frederick R Appelbaum; Mohamed L Sorror; William I Bensinger; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
2009: N Basara; A Schulze; U Wedding; M Mohren; A Gerhardt; Christian Junghanss; N Peter; Gottfried Dölken; C Becker; S Heyn; C Kliem; Thoralf Lange; R Krahl; Wolfram Pönisch; H-J Fricke; H G Sayer; Haifa-Kathrin Al-Ali; Friedrich Kamprad; Dietger Niederwieser
Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission.
Leukemia 2009;23(4):635-40.
2009: Jeffrey W Tyner; Marc Loriaux; H Erickson; C A Eide; J Deininger; Mary MacPartlin; S G Willis; Thoralf Lange; Brian J Druker; Tibor J Kovacsovics; Richard T Maziarz; N Gattermann; Michael W N Deininger
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia.
Leukemia 2009;23(2):406-9.
2008: O Pelz-Ackermann; Michael Cross; H Pfeifer; Michael W N Deininger; S-Y Wang; Haifa-Kathrin Al-Ali; Dietger Niederwieser; Thoralf Lange
Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR.
Leukemia 2008;22(12):2288-91.
2008: Andrew R Rezvani; Lalitha Norasetthada; Ted Gooley; Mohamed Sorror; Michelle E Bouvier; Firoozeh Sahebi; Edward Agura; Thomas R Chauncey; Richard T Maziarz; Michael Maris; Judith Shizuru; Benedetto Bruno; Christopher Bredeson; Thoralf Lange; Andrew Yeager; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
British journal of haematology 2008;143(3):395-403.
2008: S Tschiedel; Chiara Gentilini; Thoralf Lange; C Wölfel; T Wölfel; V Lennerz; S Stevanovic; H-G Rammensee; Christoph Huber; Michael Cross; Dietger Niederwieser
Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia.
Leukemia 2008;22(8):1542-50.
2008: Ginna G Laport; Brenda M Sandmaier; Barry E Storer; Bart L Scott; Monic J Stuart; Thoralf Lange; Michael B Maris; Edward D Agura; Thomas R Chauncey; Ruby M Wong; Stephen J Forman; Finn B Petersen; James C Wade; Elliot M Epner; Benedetto Bruno; Wolfgang A Bethge; Peter T Curtin; David G Maloney; Karl G Blume; Rainer F Storb
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):246-55.
2008: Andrew R Rezvani; Barry Storer; Michael B Maris; Mohamed L Sorror; Edward Agura; Richard T Maziarz; James C Wade; Thomas R Chauncey; Stephen J Forman; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Brenda M Sandmaier; Rainer Storb; David G Maloney
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):211-7.
2007: Frédéric Baron; Brenda M Sandmaier; Barry E Storer; Michael B Maris; Amelia A Langston; Thoralf Lange; Effie W Petersdorf; Wolfgang A Bethge; Richard T Maziarz; Peter A McSweeney; Michael Allen Pulsipher; James C Wade; Thomas R Chauncey; Judith A Shizuru; Mohamed L Sorror; Ann Woolfrey; David G Maloney; Rainer Storb
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
2007: Heike Pfeifer; Barbara Wassmann; Anna Pavlova; Lydia Wunderle; Johannes Oldenburg; Anja Binckebanck; Thoralf Lange; Andreas Hochhaus; Silvia Wystub; Patrick Brück; Dieter Hoelzer; Oliver G Ottmann
Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Blood 2007;110(2):727-34.
2007: Olaf Penack; Lars Fischer; Andrea Stroux; Chiara Gentilini; Axel Nogai; Arne Muessig; Susanne Ganepola; Thoralf Lange; Constanze Kliem; Olga Marinets; Igor Wolfgang Blau; Eckhard Thiel; Lutz Uhareka
A novel method to quantify and characterize leukemia-reactive natural killer cells in patients undergoing allogeneic hematopoietic stem cell transplantation following conventional or reduced-dose conditioning.
International journal of hematology 2007;85(4):326-32.
2007: George E Georges; Michael B Maris; David G Maloney; Brenda M Sandmaier; Mohamed L Sorror; Judith A Shizuru; Thoralf Lange; Edward D Agura; Benedetto Bruno; Peter A McSweeney; Michael Allen Pulsipher; Thomas R Chauncey; Marco Mielcarek; Barry E Storer; Rainer Storb
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):423-32.
2007: Susanne Neumann; Konrad Schoppmeyer; Thoralf Lange; Marcus Wiedmann; Johannes Golsong; Andrea Tannapfel; Joachim Mossner; Dietger Niederwieser; Karel Caca
Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease.
Gastrointestinal endoscopy 2007;65(3):403-9.
2007: Susanne Ganepola; Chiara Gentilini; U Hilbers; Thoralf Lange; Kathrin Rieger; Jörg Hofmann; M Maier; U. Liebert; Dietger Niederwieser; Elisabeth Engelmann; Regine Heilbronn; Eckhard Thiel; Lutz Uharek
Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
Bone marrow transplantation 2007;39(5):293-9.
2006: Thoralf Lange; Georg Franke; Dietger Niederwieser
Parotitis associated with a parainfluenza virus type 3 infection during aplasia after unrelated allogeneic stem cell transplantation.
Leukemia & lymphoma 2006;47(8):1714-5.
2006: Michael W N Deininger; Michael Schleuning; Hilde Greinix; Herbert G Sayer; Thomas Fischer; Jesus Martinez; Richard T Maziarz; Eduardo Olavarria; Leo Verdonck; Kerstin Schaefer; Conxa Boqué; Edgar Faber; Arnon Nagler; Enrico Pogliani; Nigel Russell; Liisa Volin; Urs Schanz; Gottfried Doelken; Michael Kiehl; Axel A Fauser; Brian J Druker; Anna Sureda; Simona Iacobelli; Ronald Brand; Rainer Krahl; Thoralf Lange; Andreas Hochhaus; Alois Gratwohl; Hans Kolb; Dietger Niederwieser
The effect of prior exposure to imatinib on transplant-related mortality.
Haematologica 2006;91(4):452-9.
2006: Ute Hegenbart; Dietger Niederwieser; Brenda M Sandmaier; Michael B Maris; Judith A Shizuru; Hildegard Greinix; Catherine Cordonnier; Bernard Rio; Alois Gratwohl; Thoralf Lange; Haifa-Kathrin Al-Ali; Barry Storer; David Maloney; Peter McSweeney; Thomas R Chauncey; Edward Agura; Benedetto Bruno; Richard T Maziarz; Finn Petersen; Rainer Storb
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):444-53.
2006: Dietger Niederwieser; Thoralf Lange; Michael Cross; Nadesda Basara; Haifa-Kathrin Al-Ali
Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.
Best practice & research. Clinical haematology 2006;19(4):825-38.
2005: Thoralf Lange; Byung S Park; Stephanie G Willis; Michael W N Deininger
BCR-ABL kinase domain mutations in chronic myeloid leukemia: not quite enough to cause resistance to imatinib therapy?
Cell cycle (Georgetown, Tex.) 2005;4(12):1761-6.
2005: Dietger Niederwieser; Chiara Gentilini; Ute Hegenbart; Thoralf Lange; Cornelia Becker; Song-Yau Wang; Kristina Bartsch; Wolfram Pönisch; Martin Raida; Haifa-Kathrin Al-Ali
Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.
Critical reviews in oncology/hematology 2005;56(2):275-81.
2005: Lucy C Crossman; Thomas O'Hare; Thoralf Lange; Stephanie G Willis; Eric P Stoffregen; Amie S Corbin; Stephen G O'Brien; Michael C Heinrich; Brian J Druker; P G Middleton; Michael W N Deininger
A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib.
Leukemia 2005;19(11):1859-62.
2005: Stephanie G Willis; Thoralf Lange; Shadmehr Demehri; Sandra Otto; Lucy C Crossman; Dietger Niederwieser; Eric P Stoffregen; Shannon McWeeney; Ines Kovacs; Byung S Park; Brian J Druker; Michael W N Deininger
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy.
Blood 2005;106(6):2128-37.
2005: Thoralf Lange; Thomas Bumm; M Mueller; S Otto; Haifa-Kathrin Al-Ali; L Grommisch; S Musiol; C Franke; Rainer Krahl; Dietger Niederwieser; Michael W N Deininger
Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation.
Leukemia 2005;19(7):1262-5.
2005: Lucy C Crossman; Motomi Mori; Yi-Ching Hsieh; Thoralf Lange; Peter Paschka; Christina A Harrington; Knut Krohn; Dietger Niederwieser; Rüdiger Hehlmann; Andreas Hochhaus; Brian J Druker; Michael W N Deininger
In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures.
Haematologica 2005;90(4):459-64.
2005: Shadmehr Demehri; Peter Paschka; Beate Schultheis; Thoralf Lange; T Koizumi; T Sugimoto; S Branford; L C Lim; T Kegel; giovanni martinelli; Andreas Hochhaus; Brian J Druker; Michael W N Deininger
e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?
Leukemia 2005;19(4):681-4.
2005: Ursula Banning; Thoralf Lange; Rainer Krahl; Christine Mauz-Körholz; Jean Krutmann; Dietger Niederwieser; Dieter Körholz
Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease.
Bone marrow transplantation 2005;35(7):691-7.
2004: Dietger Niederwieser; Chiara Gentilini; Ute Hegenbart; Thoralf Lange; P Moosmann; Wolfram Pönisch; Haifa-Kathrin Al-Ali; Martin Raida; P Ljungman; A Tyndall; A Urbano-Ispizua; H M Lazarus; Alois Gratwohl
Transmission of donor illness by stem cell transplantation: should screening be different in older donors?
Bone marrow transplantation 2004;34(8):657-65.
2004: Thoralf Lange; Michael W N Deininger; Ronald Brand; Ute Hegenbart; Haifa-Kathrin Al-Ali; Rainer Krahl; W Poenisch; Lutz Uharek; Sabine Leiblein; Chiara Gentilini; Effie W Petersdorf; Rainer Storb; Dietger Niederwieser
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Leukemia 2004;18(9):1468-75.
2004: Thoralf Lange; Thomas Bumm; Sandra Otto; Haifa-Kathrin Al-Ali; Ines Kovacs; Daniela Krug; Thomas Köhler; Rainer Krahl; Dietger Niederwieser; Michael W N Deininger
Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy.
Haematologica 2004;89(1):49-57.
2004: Haifa-Kathrin Al-Ali; Michael C Heinrich; Thoralf Lange; Rainer Krahl; Matthias Mueller; Christel Müller; Dietger Niederwieser; Brian J Druker; Michael W N Deininger
High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(1):55-60.
2003: Thoralf Lange; Dietger Niederwieser; Michael W N Deininger
Residual disease in chronic myeloid leukemia after induction of molecular remission.
The New England journal of medicine 2003;349(15):1483-4.
2003: Thoralf Lange; Christine Günther; Thomas Köhler; Rainer Krahl; Scarlet Musiol; Sabine Leiblein; Haifa-Kathrin Al-Ali; Iris van Hoomissen; Dietger Niederwieser; Michael W N Deininger
High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML.
Blood 2003;101(6):2152-5.
2003: Dietger Niederwieser; Michael B Maris; Judith A Shizuru; Effie W Petersdorf; Ute Hegenbart; Brenda M Sandmaier; David G Maloney; Barry Storer; Thoralf Lange; Thomas R Chauncey; Michael W N Deininger; Wolfram Pönisch; Claudio Anasetti; Ann Woolfrey; Marie-Térèse Little; Karl G Blume; Peter A McSweeney; Rainer F Storb
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.
Blood 2003;101(4):1620-9.
2001: Michael W N Deininger; Wolfram Pönisch; Rainer Krahl; Sabine Leiblein; E Edel; Thoralf Lange; Friedrich Fiedler; Mathias Freund; Astrid Franke; Rita Pasold; Ullrich von Grünhagen; Michael Herold; Gottfried Dölken; F A Hoffmann; R Uhle; W Schultze; J Steglich; A Schwarzer; P Richter; C Winkelmann; Erika Kettner; K Dachselt; R Subert; E Schwalbe; J Doepper; Werner Helbig; Dietger Niederwieser
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.
Bone marrow transplantation 2001;27(11):1125-32.